Goals and rationale for pharmacotherapeutic approach in treating cocaine dependence: insights from basic and clinical research
Overview of potential treatment medications for cocaine dependence
Methodologic recommendations for cocaine abuse clinical trials: a clinician-researcher's perspective
Management of clinical trials with new medications for cocaine dependence and abuse
Outcome measurement considerations: pharmacological treatments for substance abuse
Variability in treatment-seeking cocaine abusers: implications for clinical pharmacotherapy trials
Baseline assessment, study entry, and stabilization: double-blind clinical trials in drug dependence
Addiction severity index in clinical efficacy trials of medications for cocaine dependence
Cognitive-neuromotor assessment of substance abuse: focus on issues related to cocaine abuse treatment
Treatment effectiveness score as an outcome measure in clinical trials
Pharmacokinetics of cocaine: considerations when assessing cocaine use by urinalysis
Quantitative urine levels of cocaine and other substances of abuse
Use of quantitative urinalysis in monitoring cocaine use
Is quantitative urinalysis more sensitive?
Comparison of immunoassays for semiquantitative measurement of benzoylecgonine in urine
Appendix I: Workshop summary outcome measures and success criteria
Appendix II: Workshop summary clinical decision tree for cocaine addiction pharmacotherapy.